What can we help you with today?
🔗 CustomizeMedical Overview of 3-Methylglutaconic Aciduria, Type VIIB
Sources citedA rare organic aciduria characterized by increased urinary excretion of 3-methylglutaconic acid, variably associated with neutropenia (sometimes causing recurrent severe infections and potentially resulting in leukemia) and progressive neurologic manifestations, such as global developmental delay, intellectual disability, hypotonia, movement disorder, and seizures. Microcephaly, cataract, facial dysmorphism, growth retardation, endocrine abnormalities, and cardiomyopathy have also been reported. Brain imaging may show cerebral or cerebellar atrophy, or abnormalities of the basal ganglia.
Classification & codes: GARD 0017767 · Orphanet ORPHA:445038 · OMIM 616271 · ICD-10 E71.1
Sources: GARD (NIH/NCATS), Orphanet · last reviewed 2026. Educational only — not medical advice.
News & Updates
ALYFTREK shows positive Phase 3 results in children ages 2–5
Vertex plans global regulatory submissions for this pediatric age group in the first half of 2026.
Airway clearance routines that actually work for teens
3 open trials match this profile
Locations in NC, FL and GA.
3-Methylglutaconic Aciduria, Type VIIB Family Conference
Illustrative example event · location TBD
Care & management overview — 3-Methylglutaconic Aciduria, Type VIIB
Educational programming; see the cited sources on this hub.
3-Methylglutaconic Aciduria, Type VIIB News & Developments
The latest 3-Methylglutaconic Aciduria, Type VIIB research, news and registered trials — live from public sources. Each link opens the source directly; nothing here is auto-summarized or invented.
Recruiting trials
View all →Find a 3-Methylglutaconic Aciduria, Type VIIB Specialist Near You
Sample results — illustrative only. A real version would search the NPPES provider registry and CFF-certified centers by actual distance from your ZIP.
Treatment & Daily Living
Medical care plus the everyday therapies and supports relevant to 3-Methylglutaconic Aciduria, Type VIIB. Treatment is individualized — ask your specialist about the medications, procedures and therapies. Browse medications →
Media Center
News, podcasts, books & research for 3-Methylglutaconic Aciduria, Type VIIB — real coverage, links out, never re-hosted.
Audience Guides
Plain-language guidance for the people around someone with 3-Methylglutaconic Aciduria, Type VIIB — how to understand it and talk about it. AI-generated for communication, not medical advice; always confirm specifics with a clinician.
Companies Developing Treatments
Biopharma companies with registered trials for 3-Methylglutaconic Aciduria, Type VIIB — from ClinicalTrials.gov. Informational, not an endorsement, and not every program is in trials.
Preferences only — saved to your account, never shared or sold. No PHI. Sources: GARD (NIH/NCATS), Orphanet.
Tools
Every institution behind the faculty, with their affiliated experts.
Plain-language tools
For clinicians, nonprofits & industry partners.
Translates any dense medical text — papers, lab results, visit notes, jargon — into plain language.
Live on tomekohealth.com — not a demo mock-up.
Research Collaboration & Matching
Live on tomekohealth.com — not a demo mock-up.
Mental Health Toolkit
Sources citedCoping strategies, how to find a a specialist therapist, and mental-health resources built for the ups and downs of living with 3-Methylglutaconic Aciduria, Type VIIB — for patients and caregivers alike.
Preferences only — saved to your account, never shared or sold. No PHI. Sources: GARD (NIH/NCATS), Orphanet.
Grand Rounds & Accredited Education
Open Questions
Ask the community →Anyone can ask. Sign in to answer. Peer support — not medical advice, and no PHI.
Survey
Reflect on how you are doing — anonymous, with only de-identified group averages shown.
Community & Support Groups
For people living with 3-Methylglutaconic Aciduria, Type VIIB. Peer support, not medical advice; no PHI.
For caregivers and family navigating 3-Methylglutaconic Aciduria, Type VIIB.
Recent From the Community
Certified Centers of Excellence
CFF networkCare centers and specialists for 3-Methylglutaconic Aciduria, Type VIIB, from Tomeko’s verified provider directory (CMS NPPES).
Representative CFF centers — the official CFF directory has the complete, current list.
Nonprofits & Foundations
Grants & Financial Help
Representative programs — illustrative only. Eligibility and availability vary; not a guarantee of assistance.
Patient & Family Guides
Sources citedAn annual snapshot of 3-Methylglutaconic Aciduria, Type VIIB research, treatment access and outcomes, written in plain language for patients and families.
Practical starting points and things to plan for in the first year after diagnosis.
Step-by-step guidance, what to expect, and a sample daily routine.
Disclosure, accommodations, insurance transitions and workplace planning for teens and young adults with MGA7.
Sources: GARD (NIH/NCATS), Orphanet · last reviewed 2026. Educational only — not medical advice.